The International Association for the Study of Pain defines allodynia as pain due to a stimulus that does not normally provoke pain and hyperalgesia as an increased response to a stimulus, which is normally painful. However, does ''normally painful'' mean ''any stimulation of nociceptors'' or ''the subjective pain response?'' We argue that ''normally painful'' should not mean ''any stimulation of nociceptors,'' as Von Frey monofilaments may evoke a pricking sensationwhich implies the involvement of nociceptors-without necessarily leading to a subjective pain perception. In this paper, we propose that the diagnosis of either allodynia or hyperalgesia should be based on the patient's report, that is, painful versus not painful, rather than on the (sub) type of afferent fiber involved.
Q uantitative sensory testing (QST) is routinely performed in patients with neuropathic pain to quantify stimulus-dependent pain. Stimulus-dependent pain is a phenomenon that can be frequently observed in these patients and can be further subdivided in allodynia and hyperalgesia. [1] [2] [3] As we will describe below, the use of these terms may be misleading, possibly frustrating the interpretation of research in the field of QST. For example, multiple definitions for the term ''hyperalgesia'' are currently used (Table 1 ).
In 1994, the Subcommittee on Taxonomy of the International Association for the Study of Pain (IASP) formulated a widely accepted definition of pain and its associated symptoms ( Table 2 ). In our opinion, the IASP definition of hyperalgesia gives rise to a dilemma; does ''normally painful'' mean (1) any stimulation of nociceptors or (2) the subjective pain response? Both interpretations are possible. Cronje and Williamson 8 wrote an interesting article on this topic, in which they expressed their surprise that the word ''normal'' is ubiquitously used in the IASP Pain Terminology, whereas its precise definition is not determined.
In this paper, we address what we perceive to be the semantic ambiguity regarding the concepts ''hyperalgesia'' and ''allodynia.'' We argue that the difference between the two becomes less obvious in clinical practice, where the boundary between painful and nonpainful is less clear-cut. The main objective of this paper is to invite clinicians and researchers to carefully examine the semantics of the terms allodynia and hyperalgesia and to join us in the discussion.
HYPERALGESIA OR ALLODYNIA?
To illustrate our point, we refer to the results of a study that we performed in a group of patients with stimulus-dependent pain. 9 In this study, we tried to determine a mean pain threshold with Von Frey monofilaments (VFMs) in 22 patients who reported unilateral stimulus-dependent pain due to a neuropathic pain syndrome. We applied the VFMs of variable stiffness on the affected and on the contralateral nonaffected skin, according to the Method of Limits protocol. We asked the patients to indicate whether they perceived the application of the monofilament as painful or not. We also included 5 healthy participants for QST according to the same protocol. Further details on the procedure are to be found in the original paper.
As an interesting, additional finding we discovered that, although in 20 of the 22 patients a pain threshold could be determined on the affected skin, none of the VFMs were regarded as painful when applied on the nonaffected skin. As a result, we concluded that we had provoked pain with a stimulus that is normally not painful and had therefore measured allodynia. This conclusion, however, does not agree with the leading opinion in medical literature, 10, 11 which implies that QST with VFMs measures (punctate) hyperalgesia.
As mentioned before, the IASP defines allodynia as pain due to a stimulus that does not normally provoke pain. The light stroking of the skin is an example of such an innocuous stimulus, which may be perceived as painful on allodynic skin. In contrast, hyperalgesia is defined as an increased response to a stimulus that is normally painful. 4 According to these definitions, it is therefore the nature of the stimuli, normally painful versus normally nonpainful that determines the difference between the two. Although this seems to be straightforward, one question arises: What exactly is ''a normally painful stimulus?''
During the execution of our study, which was originally intended to measure pain thresholds in patients with stimulus-dependent pain, we noticed that none of the VFMs elicited a pain response on healthy skin; neither in the patients nor in the control participants. Although a mild pricking sensation was generally present upon the application of thicker VFMs, the patients and participants clearly indicated that they did not regard this as painful. The IASP definition of pain, states explicitly that ''experiences which resemble pain but are not unpleasant, for example, pricking, should not be called pain.'' 4 We therefore could not, in the absence of algesia, identify hyperalgesia. Pain is not merely the consequence of the stimulation of nociceptors; pain is a complex sensory and emotional experience. 4 
Different Subtypes of Stimulus-dependent Pain
Most of the research in the field of QST has focused on hyperalgesia, which has led to the distinction of 3 different subtypes during the 1990s: dynamic, static, and punctate hyperalgesia (see below). 1, [12] [13] [14] [15] [16] The subdivision of hyperalgesia into these 3 different subtypes has been based mainly on differences in the postulated underlying pathophysiologic mechanisms.
Dynamic Hyperalgesia
Stimuli that can be administered to provoke dynamic hyperalgesia include the light stroking of the affected skin. 14 As this form of cutaneous stimulation is certainly nonpainful on normal skin, this dynamic hyperalgesia is also referred to as ''brush-evoked allodynia'' or ''low threshold mechanoreceptor-mediated allodynia.'' Dynamic hyperalgesia is thought to be mediated by low threshold (Ab) afferent fibers, with the perception of pain being the consequence of sensitization and misinterpretation in the central nervous system. 12, [15] [16] [17] On the other hand, it may also be mediated by sensitized nociceptors (high threshold Ad-afferent and C-afferent fibers), which would normally respond only to noxious, high-intensity stimulation. 10, 18 Consequently, the pain resulting from the light stroking of the skin may be the result of stimulation of either type of afferent fiber.
Several aspects of the concept dynamic hyperalgesia need further consideration. Allodynia is often referred to as a synonym for ''dynamic hyperalgesia.'' 1, 11, 19, 20 According to the IASP definition of hyperalgesia, however, any method of QST to test hyperalgesia should also be normally painful, that is, painful on corresponding, nonaffected skin. Obviously, the light stroking of the skin is not normally painful. As a result, this method of QST does not test hyperalgesia, it tests allodynia. We argue that there is no place for the concept dynamic hyperalgesia in the field of QST.
Static Hyperalgesia
Stimuli that can be administered to provoke static hyperalgesia include applying firm pressure, pinching, stretching, or squeezing to the skin. 12, 14, 15 Static hyperalgesia is thought to be mediated mainly by Ad and C nociceptors and results from sensitization of these peripheral nociceptors. 1, 14, 21 However, input from Adnociceptors may also be exaggerated within the central nervous system. 19, 22 Furthermore, stimuli that provoke static hyperalgesia, for example, firm pressure on the skin, will inevitably activate low threshold Ab-fibers. Thus, multiple neurophysiologic mechanisms may underlie the clinical phenomenon of static hyperalgesia.
Punctate Hyperalgesia
Punctate hyperalgesia can be evoked by applying a pin or VFMs onto the affected skin. 19, 20 Punctate hyperalgesia is thought to be mediated mainly by Adnociceptors. 15, 19 VFMs are frequently used to test punctate hyperalgesia. Thin VFMs stimulate Ab-afferents, however, thick VFMs will stimulate Ad-fiber nociceptors as well, due to the sharp edges of the monofilaments. 19, 23 In case of peripheral sensitization, C-fiber nociceptors may also be involved. 1, 19, 21, 23, 24 As we 
Concept Definition
Pain An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage Allodynia Pain owing to a stimulus which does not normally provoke pain Hyperalgesia
An increased response to a stimulus which is normally painful mentioned above, there is evidence for an exaggerated response to Ad-nociceptive input at spinal level, suggesting that central sensitization also plays a role in punctate hyperalgesia. 19 Hence, when VFMs are used to quantify punctate hyperalgesia, it cannot be determined to what extent these different pathophysiologic mechanisms are involved.
In conclusion, current stimulation methods are too crude to be able to discriminate between the 3 subtypes of hyperalgesia on the basis of the underlying pathophysiologic mechanisms, of which our knowledge is still incomplete. Furthermore, it does not automatically suffice to identify any clinical or neurophysiologic phenomenon that involves nociceptors as hyperalgesia.
QUANTIFICATION OF HYPERALGESIA AND ALLODYNIA
Different pathophysiologic mechanisms often coexist in neuropathic pain. The clinical symptoms that correspond with the 2 concepts allodynia and hyperalgesia are therefore likely to co-occur in patients with neuropathic pain. However, with the careful use of QST, a distinction between the 2 subtypes of stimulusdependent pain can well be made, based on clinical findings rather than based on the assumed underlying pathophysiologic mechanisms.
To quantify the intensity of stimulus-dependent pain in general, the pain threshold is determined on affected skin, for example, using the Method of Limits. [25] [26] [27] The pain threshold can then be expressed as the intensity of the stimulus needed to evoke the participant's verbal pain response.
To quantify hyperalgesia, the (subjective) pain intensity after a stimulus that also evokes pain on healthy skin needs to be assessed with a Visual Analogue Scale or Numeric Rating Scale. After all, the stimulus intensity needed to evoke a pain response is not abnormal; it is the pain response that is exaggerated.
To quantify allodynia, the lowest intensity of a nonpainful stimulus needed to evoke a pain response on the affected skin, that is, pain incidence, can be measured. 11, 28 This option implies the measurement of stimulus intensity, not pain (eg, degrees Celsius as with thermal QST 29 ). The advantage of this method is that allodynia can be quantified objectively, as the subjective response of the patient is reduced to either ''yes (it was painful)'' or ''no (it was not painful).'' Taking this into account, is hyperalgesia a valuable additional parameter in clinical QST with VFMs or a source of semantic confusion and of limited clinical value?
CONCLUSIONS
QST of hypersensitive skin in patients with neuropathic pain is important for both clinicians and researchers. Ideally, with QST, stimulus-dependent pain should be quantifiable with a reasonable degree of objectivity, in a reliable and reproducible manner. Furthermore, it is important that it should be clear which subtype of stimulus-dependent pain is quantified, to avoid ambiguous results.
We observed that VFMs that evoked a pain response in patients with stimulus-dependent pain did not evoke a pain response when applied on healthy, unaffected skin, even though this sensation was frequently described as pricking. None of the patients or healthy participants, however, regarded this pricking sensation to be painful. Thus, we diagnosed the stimulus-dependent pain in our patients to be allodynia; as stimulation of normal skin with VFMs is not painful.
We have found that the leading opinion in medical literature states that with VFMs (punctate) hyperalgesia can be measured. This opinion is based on evidence that punctate stimuli, as with VFMs, stimulate Ad-nociceptors. The main idea behind this opinion is that normally painful implies the involvement of nociceptors, rather than the subjective pain response. In other words, hyperalgesia is increased pain after stimulation of nociceptors; whereas allodynia is pain after stimulation of Ab-fibers.
What Are We Suggesting?
First, there is no need to alter current QST technique, but in view of the above-mentioned points we propose to adjust the interpretation of the results. When pain is elicited on the affected skin, it is unlikely that Ab, Ad, or C-fiber afferents can be stimulated selectively with the current methods of QST. Therefore, the difference between allodynia and hyperalgesia should not be diagnosed on the basis of the primary afferent that is assumed to be stimulated. Instead, the diagnosis of either allodynia or hyperalgesia should be based on patients' report after stimulation of the affected skin, that is, painful or not painful, whereby corresponding, nonaffected skin is used as the reference standard. Allodynia and hyperalgesia are clinical phenomena, not neurophysiologic diagnoses.
Second, multiple definitions and interpretations of the clinical phenomenon hyperalgesia are currently used in the medical literature. In this respect, the IASP definition of hyperalgesia should be the gold standard, however, we argue that it is of limited use for clinical QST.
Needless to say, in day-to-day medical practice, diagnostic procedures to obtain a better understanding of the pathophysiologic mechanisms of neuropathic pain should entail more than just QST, such as an accurate history and a thorough physical examination. Nevertheless, QST of stimulus-dependent pain is a valuable tool in the diagnosis of neuropathic pain and it can be deployed to monitor the effect of therapeutic interventions in the treatment of neuropathic pain.
